Meal Timing on Glucose Metabolism and Hyperandrogenism in Lean Women With Polycystic Ovary Syndrome (M-PCOS)

Influence of Meal Timing on Glucose Metabolism and Hyperandrogenism in Lean Women With Polycystic Ovary Syndrome

In obese women with polycystic ovary syndrome (PCOS), weight loss improves insulin resistance and hyperandrogenism, resulting in improvement of clinical symptoms. Weight loss is not required in lean PCOS patients; nevertheless, the influence of meal timing and composition on glucose metabolism and hyperandrogenism may have clinical value. In this study the investigators investigate the effects of two isocaloric diets with different meal timing distribution on insulin resistance and hyperandrogenism in lean PCOS patients.

Study Overview

• Status: Unknown
• Conditions: Hyperandrogenism; Insulin Resistance
• Intervention / Treatment: Other: Dietary intervention

Detailed Description

Insulin resistance and hyperinsulinemia plays a pivotal role in the pathogenesis of polycystic ovary syndrome (PCOS). Hyperinsulinemia stimulates ovarian cytochrome P450c17 alpha activity, in obese and nonobese women with PCOS, thereby increasing serum levels of 17-alpha-hydroxyprogesterone, androgens concentrations, decreasing SHBG and promoting the clinical features of hyperandrogenism.

In women with PCOS, weight loss improves insulin resistance and hyperandrogenism, resulting in improvement of clinical symptoms. Since lean women with PCOS do not have the option of weight loss, it is important to know weather diet composition and meal timing distribution may influence glucose metabolism and hyperandrogenism.

We hypothesized that a timing pattern of increased nutrient intake of protein and carbohydrates in the morning, with decreased caloric intake at night would improve insulin sensitivity and hyperandrogenism in lean women with PCOS.

Objective:The objective of this study is to investigate the effects of two isocaloric diets with different meal timing distribution on insulin resistance and hyperandrogenism in lean PCOS women.

• Study Type: Interventional
• Enrollment (Anticipated): 60
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Israel
  • Tel Aviv
    • Holon, Tel Aviv, Israel, 58100
      • Daniela Jakubowicz

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 45 years (ADULT)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: Female

Description

Inclusion Criteria:

1. Subjects ≥18 and ≤45 years of age
2. Lean women with PCOS (BMI: ≤ 25 kg/m2)
3. Signed informed consent
4. Exclusion of late-onset adrenal hyperplasia by a fasting serum 17- hydroxy progesterone concentration below 200 ng/dl.
5. Acceptable health based on interview, medical history, physical examination, and laboratory tests (SMA20 and CBC).
6. Not dieting and no change in body weight >10 lb = 4.5 kg within the last 6 months
7. Stable physical activity pattern during the three months immediately preceding study initiation
8. Hyperandrogenemia (elevated free testosterone).
9. Normal liver and kidney function
10. Fasting blood glucose <110 mg/dl.
11. No metabolic disease
12. Usually wakes up between 05:00 and 07:00 and goes to sleep between 22:00 and 24:00.
13. Normal TSH and FT4 levels and serum prolactin
14. Acceptable health based on interview, medical history, physical examination, and laboratory tests

Exclusion Criteria:

1. Diabetes mellitus diagnosed by fasting glucose or a 2-hour OGTT, or fasting glucose > 110 mg/dl
2. Clinically significant pulmonary, cardiac, renal, hepatic, neurologic, psychiatric, infectious, malignant disease (other than skin cancer).
3. Current use of oral contraceptives
4. Serum creatinine level > 1.5 mg/dl
5. Abnormal liver function tests defined as an increase by a factor of at least 2 above the upper normal limit of alanine aminotransferase and/or aspartate
6. Any physiologic or mechanical problems preventing dietary adherence
7. Pregnant or lactating
8. Participating in another dietary program or use of weight-loss medications
9. Documented or suspected history (within one year) of illicit drug abuse or alcoholism.
10. Use of psychotropic or anoretic medication during the month immediately prior to study onset
11. Night or rotating shift work

12. Jet lag during the 2 week period immediately prior to study onset

    -

Study Plan

How is the study designed?

Design Details

• Primary Purpose: SUPPORTIVE_CARE
• Allocation: RANDOMIZED
• Interventional Model: PARALLEL
• Masking: NONE

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
EXPERIMENTAL: Lifestyle counseling; Lifestyle counseling, with high calorie breakfast	Other: Dietary intervention; High Calorie breakfast and high calorie dinner
ACTIVE_COMPARATOR: Life Counseling; Diet with high calorie dinner	Other: Dietary intervention; High Calorie breakfast and high calorie dinner

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
hyperandrogenism	Androgens will be evaluate at baseline and after one of two isocaloric diet that differe in meal timing distribution	90 days

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
glucose metabolism	Glucose metabolism will be evaluated at baseline and after one of two isocaloric diets that differ in meal timing distribution	90 days

Collaborators and Investigators

• Sponsor: Tel Aviv University
• Investigators: Study Director: Mona Boaz, PhD, E. Wolfson Medical Center Tel Aviv University; Study Chair: Julio Wainstein, MD, E. Wolfson Medical Center

Study record dates

Study Major Dates

• Study Start: March 1, 2012
• Primary Completion (ACTUAL): June 1, 2012
• Study Completion (ANTICIPATED): June 1, 2015

Study Registration Dates

• First Submitted: March 30, 2012
• First Submitted That Met QC Criteria: April 2, 2012
• First Posted (ESTIMATE): April 3, 2012

Study Record Updates

• Last Update Posted (ESTIMATE): April 8, 2015
• Last Update Submitted That Met QC Criteria: April 7, 2015
• Last Verified: April 1, 2015

More Information

Terms related to this study

• Keywords: PCOS
• Additional Relevant MeSH Terms: Glucose Metabolism Disorders; Metabolic Diseases; Neoplasms; Endocrine System Diseases; Ovarian Cysts; Cysts; Ovarian Diseases; Adnexal Diseases; Gonadal Disorders; 46, XX Disorders of Sex Development; Disorders of Sex Development; Urogenital Abnormalities; Adrenogenital Syndrome; Congenital Abnormalities; Hyperinsulinism; Polycystic Ovary Syndrome; Hyperandrogenism; Insulin Resistance
• Other Study ID Numbers: 0048-12-WOMC